MERSANA THERAPEUTICS INC — Form D

MERSANA THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-24. The offering totals $33.1M, of which $33.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (48)

Showing 25 of 48 people.

NameRoleLocation
THOMAS J BECKDirectorCAMBRIDGE, MA
ELAINE J JONESDirectorCAMBRIDGE, MA
David MottDirectorChevy Chase, MD
Sara J NayeemDirectorBOSTON, MA
ANNA PROTOPAPASDirectorCAMBRIDGE, MA
DONALD BERGSTROMExecutive OfficerCAMBRIDGE, MA
WAYNE J FOSTERExecutive OfficerCAMBRIDGE, MA
EVA JACKExecutive OfficerCAMBRIDGE, MA
Michael J KaufmanExecutive OfficerNew York, NY
TIMOTHY LOWINGERExecutive OfficerCAMBRIDGE, MA
ANNA PROTOPAPASExecutive OfficerCAMBRIDGE, MA
Peter ParkExecutive OfficerSan Francisco, CA
Sara NayeemDirectorMenlo Park, CA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
C. Boyd ClarkeDirectorMadison, WI
Thomas BeckDirectorMilwaukee, WI
David G MottDirectorCAMBRIDGE, MA
Sara G NayeemDirectorCAMBRIDGE, MA
David MottExecutive OfficerChevy Chase, MD
WAYNE FOSTERExecutive OfficerCAMBRIDGE, MA
Wayne B FosterExecutive OfficerCambridge, MA
Nicholas G BacopoulosDirectorCambridge, MA
Nicholas G BacopoulosExecutive OfficerCambridge, MA
Timothy B LowingerExecutive OfficerCambridge, MA
Thomas G BeckDirectorCambridge, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2016-03-01D/A$35.5M$10.1M
2015-03-03D$35.5M$10.1M
2014-04-08D/A$14.5M$14.5M
2013-10-09D$14.5M$5.0M
2012-08-09D$27.0M$12.5M
2012-04-18D/A$10.0M$10.0M
2011-04-21D$10.0M$6.0M
2010-02-26D$3.5M$2.5M

More